Possible role of LECT2 as an intrinsic regulatory factor in SEA-induced toxicity in d-galactosamine-sensitized mice

Clinical Immunology

Volumn 137, Issue 3, 2010, Pages 311-321

  Dang, Minh Hung ^a   Kato, Hidehito ^a   Ueshiba, Hidehiro ^a   Omori Miyake, Miyuki ^a   Yamagoe, Satoshi ^b   Ando, Kazuyoshi ^a   Imanishi, Ken'ichi ^a   Arimura, Yutaka ^a   Haruta, Ikuko ^a   Kotani, Tohru ^a   Ozaki, Makoto ^a   Suzuki, Kazuo ^b,c   Uchiyama, Takehiko ^d   Yagi, Junji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d TOKIWA UNIVERSITY   (Japan)

Author keywords

Cytokines; DIC; Inflammation; LECT2; Liver failure; Multiple organ failure; Staphylococcal enterotoxin A; Toxic shock syndrome

Indexed keywords

CHEMOTAXIN; CYTOKINE; GALACTOSAMINE; INTERLEUKIN 6; LEUKOCYTE CELL DERIVED CHEMOTAXIN 2; STAPHYLOCOCCUS ENTEROTOXIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; LETHALITY; LIVER HEMORRHAGE; LUNG HEMORRHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; SURVIVAL; TOXIC SHOCK SYNDROME;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG-INDUCED LIVER INJURY; ENTEROTOXINS; FEMALE; FLOW CYTOMETRY; GALACTOSAMINE; HEMORRHAGE; IN SITU NICK-END LABELING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; LIVER; LUNG; MICE; MICE, INBRED C57BL; SHOCK, SEPTIC; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149283852     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.08.002     Document Type: Article

References (39)

1. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978, 2:1116-1118.
2. Todd J.K. Toxic shock syndrome. Clin. Microbiol. Rev. 1988, 1:432-446.
3. Uchiyama T., Imanishi K., Miyoshi-Akiyama T., Kato H. Staphylococcal superantigens and the diseases they cases. The comprehensive sourcebook of bacterial protein toxins 2006, 830-843. Elsevier, Amsterdam. J.E. Alouf, M.R. Popoff (Eds.).
4. Larkin S.M., Williams D.N., Osterholm M., Tofte R.W., Posalaky Z. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann. Intern. Med. 1982, 96:858-864.
5. Paris A.L., Herwaldt L.A., Blum D., Schmid G.P., Shands K.N., Broome C.V. Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann. Intern. Med. 1982, 96:852-857.
6. White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989, 56:27-35.
7. Yagi J., Baron J., Buxser S., Janeway C.A. Bacterial proteins that mediate the association of a defined subset of T cell receptor: CD4 complexes with class II MHC. J. Immunol. 1990, 144:892-901.
8. Choi Y.W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:8941-8945.
9. Chatila T., Scholl P., Spertini F., Ramesh N., Trede N., Fuleihan R., Geha R.S. Toxic shock syndrome toxin-1, toxic shock, and the immune system. Curr. Top. Microbiol. Immunol. 1991, 174:63-79.
10. Kotzin B.L., Leung D.Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 1993, 54:99-166.
11. Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., Kotzin B.L. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 1990, 172:981-984.
12. Matsuda Y., Kato H., Yamada R., Okano H., Ohta H., Imanishi K., Kikuchi K., Totsuka K., Uchiyama T. Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor Vβ2-positive T cells. Emerg. Infect. Dis. 2003, 9:387-389.
13. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990, 248:705-711.
14. Uchiyama T., Yan X.-J., Imanishi K., Yagi J. Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol. Immunol. 1994, 38:245-256.
15. Anderson M.R., Tary-Lehmann M. Staphylococcal enterotoxin-B-induced lethal shock in mice is T-dependent, but disease susceptibility is defined by the non-T-cell compartment. Clin. Immunol. 2001, 98:85-94.
16. Saha B., Jaklic B., Harlan D.M., Gray G.S., June C.H., Abe R. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig. J. Immunol. 1996, 157:3869-3875.
17. Aoki Y., Hiromatsu K., Arai T., Usami J., Makino M., Ishida H., Yoshikai Y. Lethal shock is inducible by lipopolysaccharide but not by superantigen in mice with retrovirus-induced immunodeficiency syndrome. J. Immunol. 1995, 155:3494-3500.
18. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P.H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 1992, 175:91-98.
19. Miyoshi-Akiyama T., Fujimaki W., Yan X.-J., Yagi J., Imanishi K., Kato H., Tomonari K., Uchiyama T. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice. Microbiol. Immunol. 1997, 41:345-352.
20. Mignon A., Rouquet N., Fabre M., Martin S., Pagès J.C., Dhainaut J.F., Kahn A., Briand P., Joulin V. LPS challenge in d-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am. J. Respir. Crit. Care Med. 1999, 159:1308-1315.
21. + T cells. J. Immunol. 2002, 168:3817-3824.
22. Yamagoe S., Yamakawa Y., Matsuo Y., Minowada J., Mizuno S., Suzuki K. Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol. Lett. 1996, 52:9-13.
23. Hiraki Y., Inoue H., Kondo J., Kamizono A., Yoshitake Y., Shukunami C., Suzuki F. A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. Purification and amino acid sequence. J. Biol. Chem. 1996, 271:22657-22662.
24. Saito T., Okumura A., Watanabe H., Asano M., Ishida-Okawara A., Sakagami J., Sudo K., Hatano-Yokoe Y., Bezbradica J.S., Joyce S., Abo T., Iwakura Y., Suzuki K., Yamagoe S. Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis. J. Immunol. 2004, 173:579-585.
25. Yamagoe S., Watanabe T., Mizuno S., Suzuki K. The mouse Lect2 gene: cloning of cDNA and genomic DNA, structural characterization and chromosomal localization. Gene 1998, 216:171-178.
26. Lehmann V., Freudenberg M.A., Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice. J. Exp. Med. 1987, 165:657-663.
27. Chojkier M., Fierer J. d-Galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 1985, 88:115-121.
28. Esmon C.T. Interactions between the innate immune and blood coagulation systems. Trends Immunol. 2004, 25:536-542.
29. Niessen F., Schaffner F., Furlan-Freguia C., Pawlinski R., Bhattacharjee G., Chun J., Derian C.K., Andrade-Gordon P., Rosen H., Ruf W. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008, 452:654-658.
30. Yamagoe S., Mizuno S., Suzuki K. Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liver. Biochim. Biophys. Acta 1998, 1396:105-113.
31. Sato Y., Watanabe H., Kameyama H., Kobayashi T., Yamamoto S., Takeishi T., Hirano K., Oya H., Nakatsuka H., Watanabe T., Kokai H., Yamagoe S., Suzuki K., Oya K., Kojima K., Hatakeyama K. Serum LECT2 level as a prognostic indicator in acute liver failure. Transplant. Proc. 2004, 36:2359-2361.
32. Sato Y., Watanabe H., Kameyama H., Kobayashi T., Yamamoto S., Takeishi T., Hirano K., Oya H., Nakatsuka H., Watanabe T., Kokai H., Yamagoe S., Suzuki K., Oya K., Kojima K., Hatakeyama K. Changes in serum LECT 2 levels during the early period of liver regeneration after adult living related donor liver transplantation. Transplant. Proc. 2004, 36:2357-2358.
33. Ohtomi M., Nagai H., Ohtake H., Uchida T., Suzuki K. Dynamic change in expression of LECT2 during liver regeneration after partial hepatectomy in mice. Biomed. Res. 2007, 28:247-253.
34. Handin R.I. Disorders of coagulation and thrombosis. Harrison's Principles of Internal Medicine 2005, 680-687. McGraw Hill Medical, New York. D.L. Kasper, E. Braunwald, A.S. Fauci, S.L. Hauser, D.L.J. Longo, J. Larry (Eds.).
35. Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998, 351:1614-1619.
36. Takahashi N., Kato H., Imanishi K., Miwa K., Yamanami S., Nishida H., Uchiyama T. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J. Clin. Invest. 2000, 106:1409-1415.
37. Kameoka Y., Yamagoe S., Hatano Y., Kasama T., Suzuki K. Val58Ile polymorphism of the neutrophil chemoattractant LECT2 and rheumatoid arthritis in the Japanese population. Arthritis. Rheum. 2000, 43:1419-1420.
38. Okumura A., Saito T., Otani I., Kojima K., Yamada Y., Ishida-Okawara A., Nakazato K., Asano M., Kanayama K., Iwakura Y., Suzuki K., Yamagoe S. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis. Arthritis. Rheum. 2008, 58:413-421.
39. Green R.S., Stone E.L., Tenno M., Lehtonen E., Farquhar M.G., Marth J.D. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity 2007, 27:308-320.